Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased

Utah Medical Products (UTMD) Shares Issued (2016 - 2024)

Utah Medical Products has reported Shares Issued over the past 15 years, most recently at $294000.0 for Q2 2024.

Quarterly results put Shares Issued at $294000.0 for Q2 2024, up 390.0% from a year ago — trailing twelve months through Mar 2025 was $294000.0 (up 53.12% YoY), and the annual figure for FY2024 was $390000.0, up 233.33%.
Shares Issued for Q2 2024 was $294000.0 at Utah Medical Products, up from $96000.0 in the prior quarter.
Over the last five years, Shares Issued for UTMD hit a ceiling of $294000.0 in Q2 2024 and a floor of $3000.0 in Q2 2021.
Median Shares Issued over the past 5 years was $60000.0 (2023), compared with a mean of $94058.8.
Biggest five-year swings in Shares Issued: crashed 90.32% in 2021 and later skyrocketed 1400.0% in 2023.
Utah Medical Products' Shares Issued stood at $76000.0 in 2020, then skyrocketed by 267.11% to $279000.0 in 2021, then plummeted by 53.05% to $131000.0 in 2022, then crashed by 72.52% to $36000.0 in 2023, then skyrocketed by 716.67% to $294000.0 in 2024.
The last three reported values for Shares Issued were $294000.0 (Q2 2024), $96000.0 (Q1 2024), and $36000.0 (Q3 2023) per Business Quant data.